
Arakis Limited
Focuses on discovery and development of inflammatory diseases and oncology adjunctive therapy.
HQ location
London, United Kingdom
Website
Launch date
Enterprise value
$141m
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
investor investor | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
investor investor investor | €0.0 | round | |
£107m Valuation: £107m | Acquisition | ||
Total Funding | 000k |

Novo Holdings(exited)

Scottish Equity Partners(exited)

Excalibur Fund Managers(exited)

3i Group(exited)

Nomura(exited)

Alice Ventures(exited)

Novo Seeds(exited)
Related Content
Notes (0)
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.